Nicodrops Issues Demand Letter to Quigley Manufacturing for Damages

Company Alleges Major Damages Suffered Due to Manufacturer Printing Incorrect Expiration Dates


LA MESA, Calif., Feb. 10, 2006 (PRIMEZONE) -- Nicodrops, Inc. (Pink Sheets:NCDP), developer of the drug-free, non-nicotine smoking alternative, herbal dietary supplement, LOZENGE (i), has served Quigley Manufacturing Inc. (Nasdaq:QGLY) with a letter demanding payment of damages Nicodrops believes it has suffered due to the majority of the packaging on orders shipped directly by Quigley to Walgreens and CVS containing premature expiration dates. The incorrect dates led many customers who would have otherwise purchased Nicodrops to decide not to do so because it appeared that the products being offered for sale were near or past their expiration dates.

Nicodrops has suffered not only customer loss but also the deterioration of its relationships with major distributors. Nicodrops believes that its damages could exceed several million dollars.

The demand letter has requested an immediate resolution of this matter in order to avoid Nicodrops filing a lawsuit against Quigley.

Nicodrops, Inc., La Mesa, Calif., developed a drug-free, non-nicotine product which helps reduce the stress associated with not smoking, using all natural herbs.(i) For more information go to http://www.nicodrops.com or call 1-866-844-5383.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. The words "believe," "expect," "anticipate," and "project," and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. Such statements may include, but not be limited to, projections of revenues, income or loss, expenses, plans, and assumptions relating to the foregoing. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future results could differ materially from those described in forward-looking statements.

(i) These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.



            

Contact Data